USZ BioResource COVID-19

Regina Grossmann150 enrolled

Overview

Mono-centric. Blood sampling for biobank development, including linkage to patient data (resource for research on COVID19).

Study Type

OBSERVATIONAL

Enrollment

150

Conditions

COVID19

Interventions

blood sampling for biobankOTHER

blood sampling for biobank

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * m/f age \> 18 years * SARS-CoV-2 infektion (according to WHO guideline) * hospitalisation, general ward * acceptable language knowledge * voluntary IFC and biobank appendix Exclusion Criteria: * contra indication for blood sampling

Locations (1)

University Hospital Zurich, Clinical Trials Center

Zurich, Switzerland

Outcomes

Primary Outcomes

blood sampling for biobank

development of a biobank

Time frame: 2 years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.